Phase 2 Trial of Neovacs’ Lupus Interferon Immunotherapy Receives Another Review Board Sign-off – Lupus News Today
Lupus News Today |
Phase 2 Trial of Neovacs' Lupus Interferon Immunotherapy Receives Another Review Board Sign-off
Lupus News Today Neovacs' Phase 2b clinical trial of an interferon immunotherapy for lupus is going according to plan, the company announced after an independent review board declined to recommend modifications to the study. The trial is evaluating interferon (IFN … |
